These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24319079)

  • 1. Adverse drug events in critically ill patients with cancer: incidence, characteristics, and outcomes.
    Nazer LH; Hawari F; Al-Najjar T
    J Pharm Pract; 2014 Apr; 27(2):208-13. PubMed ID: 24319079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
    Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
    Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug events resulting in admission to the intensive care unit in oncology patients: Incidence, characteristics and associated cost.
    Nazer LH; Eljaber R; Rimawi D; Hawari FI
    J Oncol Pharm Pract; 2013 Dec; 19(4):298-304. PubMed ID: 23223402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of adverse drug events on morbidity and mortality in intensive care units: the JADE study.
    Ohta Y; Sakuma M; Koike K; Bates DW; Morimoto T
    Int J Qual Health Care; 2014 Dec; 26(6):573-8. PubMed ID: 25192926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of adverse drug events in an academic hospital: a prospective cohort study.
    Aljadhey H; Mahmoud MA; Mayet A; Alshaikh M; Ahmed Y; Murray MD; Bates DW
    Int J Qual Health Care; 2013 Dec; 25(6):648-55. PubMed ID: 24141014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summaries.
    Anthes AM; Harinstein LM; Smithburger PL; Seybert AL; Kane-Gill SL
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):510-6. PubMed ID: 23440931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug events identified by triggers at a teaching hospital in Brazil.
    Giordani F; Rozenfeld S; Martins M
    BMC Pharmacol Toxicol; 2014 Dec; 15():71. PubMed ID: 25496209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of vendor computerized physician order entry on patients with renal impairment in community hospitals.
    Leung AA; Schiff G; Keohane C; Amato M; Simon SR; Cadet B; Coffey M; Kaufman N; Zimlichman E; Seger DL; Yoon C; Bates DW
    J Hosp Med; 2013 Oct; 8(10):545-52. PubMed ID: 24101539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a ward-based pharmacy team on preventable adverse drug events in surgical patients (SUREPILL study).
    Surgery and Pharmacy in Liaison (SUREPILL) Study Group
    Br J Surg; 2015 Sep; 102(10):1204-12. PubMed ID: 26179814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
    Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
    JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detecting adverse drug events during the hospital stay].
    Berga Culleré C; Gorgas Torner MQ; Altimiras Ruiz J; Tuset Creus M; Besalduch Martín M; Capdevila Sunyer M; Torres Gubert M; Casajoana Cortinas MT; Baró Sabaté E; Fernández Solà JR; Moron i Besolí A; Odena Estradé E; Serrais Benavente J; Vitales Farrero MT; Codina Jané C
    Farm Hosp; 2009; 33(6):312-23. PubMed ID: 20038390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugs.
    Roulet L; Ballereau F; Hardouin JB; Chiffoleau A; Potel G; Asseray N
    J Emerg Med; 2014 Jun; 46(6):857-64. PubMed ID: 24565882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug events in surgical patients: an observational multicentre study.
    de Boer M; Boeker EB; Ramrattan MA; Kiewiet JJ; Dijkgraaf MG; Boermeester MA; Lie-A-Huen L
    Int J Clin Pharm; 2013 Oct; 35(5):744-52. PubMed ID: 23722455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational study.
    Eshetie TC; Hailemeskel B; Mekonnen N; Paulos G; Mekonnen AB; Girma T
    BMC Pediatr; 2015 Jul; 15():83. PubMed ID: 26173560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital admissions caused by adverse drug events: an Australian prospective study.
    Phillips AL; Nigro O; Macolino KA; Scarborough KC; Doecke CJ; Angley MT; Shakib S
    Aust Health Rev; 2014 Feb; 38(1):51-7. PubMed ID: 24351707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study.
    Aljadhey H; Mahmoud MA; Ahmed Y; Sultana R; Zouein S; Alshanawani S; Mayet A; Alshaikh MK; Kalagi N; Al Tawil E; El Kinge AR; Arwadi A; Alyahya M; Murray MD; Bates D
    BMJ Open; 2016 Jul; 6(7):e010831. PubMed ID: 27406640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing characteristics of adverse drug events between older and younger adults presenting to a Taiwan emergency department.
    Chen YC; Huang HH; Fan JS; Chen MH; Hsu TF; Yen DH; Huang MS; Wang CY; Huang CI; Lee CH
    Medicine (Baltimore); 2015 Feb; 94(7):e547. PubMed ID: 25700322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug events in an intensive care unit of a university hospital.
    Reis AM; Cassiani SH
    Eur J Clin Pharmacol; 2011 Jun; 67(6):625-32. PubMed ID: 21246350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.